EIGR Shares Outstanding History



Below is a table of the EIGR shares outstanding history going back to 3/23/2016:

Date EIGR Shares Outstanding
3/23/201653147
3/31/2016231513
8/4/2016236830
11/3/2016278555
3/16/2017278707
5/4/2017278901
8/3/2017278901
11/3/2017350547
3/2/2018350887
5/7/2018351337
8/6/2018474809
11/5/2018636518
3/11/2019642015
5/6/2019814515
8/5/2019814858
11/4/2019816502
3/5/2020818634
5/4/2020835213
8/3/2020974766
11/2/20201.08M
3/5/20211.13M
5/3/20211.13M
8/2/20211.13M
11/1/20211.13M
3/7/20221.15M
5/2/20221.44M
8/1/20221.47M
11/1/20221.47M
3/13/20231.47M
5/8/20231.48M
8/9/20231.48M
11/6/20231.48M
4/4/20241.48M

Also see: EIGR Market Cap History
EIGR YTD Return
EIGR Historical Shares Outstanding:
+51.27% CAGR
EIGR Historical Shares Outstanding: +51.27% CAGR

Mouse over chart for data details
3/23/2016 ...4/4/2024
Eiger BioPharmaceuticals is a commercial-stage biopharmaceutical company. Co.'s portfolio includes a late-stage clinical development pipeline with five clinical product candidates and one U.S. Food and Drug Administration (FDA)-approved product. Co.'s clinical product candidates include: Lonafarnib for Hepatitis Delta Virus (HDV), Peginterferon Lambda for HDV, Combination Therapy for HDV; Peginterferon Lambda (lambda) for COVID-19, Avexitide in Congenital Hyperinsulinism, and Avexitide in Post-Bariatric Hypoglycemia. Co. has received FDA approval for Zokinvy to reduce the risk of mortality in Progeria and to treat processing-deficient Progeroid Laminopathies. We show 33 historical shares outstanding datapoints in our coverage of EIGR's shares outstanding history.

Understanding the changing numbers of EIGR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like EIGR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching EIGR by allowing them to research EIGR shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree EIGR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Eiger BioPharmaceuticals (EIGR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

EKSO Shares Outstanding History
ELAN Shares Outstanding History
ELDN Shares Outstanding History
ELEV Shares Outstanding History
ELGX Shares Outstanding History
ELOX Shares Outstanding History
ELUT Shares Outstanding History
ELVN Shares Outstanding History
ELYM Shares Outstanding History
EMBC Shares Outstanding History
More Healthcare companies »

 

EIGR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.